Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.7480
-0.0700 (-8.56%)
At close: Mar 2, 2026

STO:KLAR Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
184164484969320
Market Cap Growth
-20.81%237.81%-1.44%-28.31%-78.53%-1.82%
Enterprise Value
184162484763294
Last Close Price
0.750.670.330.451.135.64
PS Ratio
20.4818.2321.575.8211.7052.30
PB Ratio
-47.43-42.2314.671.200.904.61
EV/Sales Ratio
20.5118.0221.335.5510.7048.07
Debt / Equity Ratio
-0.16-0.167.390.490.240.46
Net Debt / Equity Ratio
-0.07-0.077.210.460.020.09
Net Debt / EBITDA Ratio
-0.02-0.02-1.19-0.88-0.03-0.09
Net Debt / FCF Ratio
-0.01-0.01-2.00-2.06-0.03-0.25
Asset Turnover
0.180.180.040.090.050.05
Quick Ratio
0.050.050.040.100.470.57
Current Ratio
0.050.050.050.140.930.58
Return on Equity (ROE)
---214.91%-61.06%-87.66%-59.81%
Return on Assets (ROA)
-32.18%-32.18%-30.03%-20.82%-29.05%-40.37%
Return on Capital Employed (ROCE)
773.70%773.70%-797.70%-78.20%-72.50%-115.00%
Earnings Yield
-21.14%-23.74%-98.47%-72.73%-92.92%-16.75%
FCF Yield
--21.39%-24.55%-18.41%-72.52%-7.76%
Buyback Yield / Dilution
-49.19%-49.19%-25.62%-73.49%-12.15%-19.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.